About
Science for industryPress
Participants
Knowledge-generating bodiesStartupsCompaniesInvestors
Summit
SpeakersAgendaTickets
Past Editions
S4i 2024S4i 2025
Catalogues
PatentsPrototypesChallenges
Get your tickets
About
Science for industryPress
Participants
Knowledge-generating bodiesStartupsCompaniesInvestors
Summit
AgendaSpeakersTickets
Past Editions
S4i 2024S4i 2025
Catalogues
PatentsPrototypesChallenges
Get your tickets
Science for Industry
La Nave Madrid
C. Cifuentes, 5, 28021, Madridmarketing@s4industry.eu

IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF BREAST CANCER

Patent number:

EP21382448

Galicia.svg
No items found.

The present invention refers to an in vitro method for the diagnosis and/or prognosis of breast cancer. The method of the invention is carried out by determining the concentration level of proteins in erythrocytes or red blood cells (RBCs) comprised in patient blood samples.

Countries:
Spain
Regions:
Galicia
Centers:
SERVIZO GALEGO DE SAUDE, UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, OTHER
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

These types of biomarkers could help detecting metastatic breast cancer early and non-invasively, reducing costs and influencing directly on the patients quality of life. These biomarkers would allow to adapt the treatments to the phase of the disease, avoiding unnecessary treatments and reducing the levels of toxicity or secondary effects.

Comments

Other related patents

Health

Selective HASPIN inhibitors

Countries
Spain
Know more
Industrial Biotech
Health

Lactiplantibacillus pentosus strain

Countries
Spain
Know more
Health

IN VITRO METHOD FOR DETECTING TUMOR GROWTH AND DIAGNOSING OR PROGNOSTICATING THE RISK OF METASTASIS IN A HUMAN SUBJECT THAT HAS BEEN DIAGNOSED WITH UVEAL MELANOMA

Countries
Spain
Know more
Get back to patents directory